Download PDF
1 / Pages

Other users also viewed these articles

Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists Lucy Gracen; Withma Muthukumara; Melanie Aikebuse; Anthony Russell; James O'Beirne; Katharine M. Irvine; Suzanne Williams; Gaurav Puri; Patricia C. Valery; Kelly L. Hayward; Elizabeth E. Powell;
Ann Hepatol. 2023;28:
Liver decompensation is a frequent cause of treatment discontinuation and prognostic factor in intermediate-advanced HCC Federico Piñero; Margarita Anders; Carla Bermudez; Ezequiel Demirdjian; Adriana Varón; Ana Palazzo; Jorge Rodriguez; Oscar Beltrán; Leonardo Gomes da Fonseca; Ezequiel Ridruejo; Pablo Caballini; Norberto Tamagnone; Virginia Reggiardo; Hugo Cheinquer; Alexandre Araujo; Diego Arufe; Juan Ignacio Marín; Natalia Ratusnu; Estela Manero; Daniela Perez; Marina Villa; Federico Orozco; Dolores Murga; Sebastián Marciano; Fernando Bessone; Marcelo Silva; Manuel Mendizabal;
Ann Hepatol. 2023;28:
LI-RADS 4 or 5 categorization may not be clinically relevant for decision-making processes: A prospective cohort study Federico Piñero; Marcos A. Thompson; Federico Diaz Telli; Juan Trentacoste; Carlos Padín; Manuel Mendizabal; Carla Colaci; Ariel Gonzalez Campaña; Josefina Pages; Silvina Montal; Mariano Barreiro; Martín Fauda; Gustavo Podestá; Juan Pablo Perotti; Marcelo Silva;
Ann Hepatol. 2020;19:662-7